Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -6.84 Million AUD | 31.23% |
| 2023 | -9.95 Million AUD | -74.49% |
| 2022 | -5.7 Million AUD | 5.22% |
| 2021 | -6.02 Million AUD | 34.68% |
| 2020 | -9.21 Million AUD | -82.35% |
| 2019 | -5.05 Million AUD | -3.16% |
| 2018 | -4.9 Million AUD | 4.82% |
| 2017 | -5.14 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -3.69 Million AUD | -17.23% |
| 2024 FY | -6.84 Million AUD | 31.23% |
| 2024 Q2 | -3.15 Million AUD | 25.2% |
| 2023 Q4 | -4.21 Million AUD | 26.63% |
| 2023 Q2 | -5.74 Million AUD | -74.96% |
| 2023 FY | -9.95 Million AUD | -74.49% |
| 2022 Q2 | -2.42 Million AUD | 30.16% |
| 2022 FY | -5.7 Million AUD | 5.22% |
| 2022 Q4 | -3.28 Million AUD | -35.41% |
| 2021 Q2 | -2.54 Million AUD | 63.35% |
| 2021 FY | -6.02 Million AUD | 34.68% |
| 2021 Q4 | -3.47 Million AUD | -36.13% |
| 2020 FY | -9.21 Million AUD | -82.35% |
| 2020 Q4 | -6.95 Million AUD | -207.92% |
| 2020 Q2 | -2.25 Million AUD | 22.69% |
| 2019 FY | -5.05 Million AUD | -3.16% |
| 2019 Q4 | -2.92 Million AUD | -37.08% |
| 2019 Q2 | -2.13 Million AUD | 0.0% |
| 2018 FY | -4.9 Million AUD | 4.82% |
| 2017 FY | -5.14 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 80.967% |
| Adherium Limited | -10.22 Million AUD | 33.023% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 29.754% |
| Anteris Technologies Ltd | -67.33 Million AUD | 89.83% |
| Control Bionics Limited | -5.91 Million AUD | -15.794% |
| CardieX Limited | -6.76 Million AUD | -1.219% |
| Compumedics Limited | -338 Thousand AUD | -1925.977% |
| Cochlear Limited | 356.8 Million AUD | 101.919% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -118.98% |
| Cyclopharm Limited | -4.7 Million AUD | -45.673% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -150.871% |
| Nova Eye Medical Limited | -8.79 Million AUD | 22.096% |
| HeraMED Limited | -6.78 Million AUD | -0.945% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 69.735% |
| ImpediMed Limited | -19.79 Million AUD | 65.398% |
| InhaleRx Limited | -1.44 Million AUD | -374.464% |
| LBT Innovations Limited | -3.74 Million AUD | -83.096% |
| Micro-X Limited | -9.76 Million AUD | 29.874% |
| Neurotech International Limited | -5.06 Million AUD | -35.085% |
| OncoSil Medical Limited | -11.91 Million AUD | 42.521% |
| PolyNovo Limited | 5.26 Million AUD | 230.162% |
| Respiri Limited | -7.12 Million AUD | 3.948% |
| SomnoMed Limited | -12.24 Million AUD | 44.062% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -1.576% |
| Uscom Limited | -2.07 Million AUD | -230.055% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -35.244% |